Literature DB >> 2846013

Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23).

J C Richards1, M B Perry.   

Abstract

The specific capsular polysaccharide of Streptococcus pneumoniae serotype 23F (American type 23) is composed of a repeating tetrasaccharide unit containing D-glucose (one part), D-galactose (one part), L-rhamnose (two parts), glycerol (one part), and phosphate (one part). By composition analysis, optical rotation, partial hydrolysis, periodate oxidation, methylation, and high-resolution 1H and 13C nuclear magnetic resonance studies, the elucidated unambiguous structure was in agreement with our earlier proposal but is at variance with structures proposed later by other authors. The structure of the type 23F pneumococcal polysaccharide is (formula; see text).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846013     DOI: 10.1139/o88-087

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

1.  Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters.

Authors:  S M Jiang; L Wang; P R Reeves
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Discovery of a novel protein modification: alpha-glycerophosphate is a substituent of meningococcal pilin.

Authors:  E Stimson; M Virji; S Barker; M Panico; I Blench; J Saunders; G Payne; E R Moxon; A Dell; H R Morris
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 3.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

4.  The use of 1H-31P GHMBC and covariance NMR to unambiguously determine phosphate ester linkages in complex polysaccharide mixtures.

Authors:  Edward R Zartler; Gary E Martin
Journal:  J Biomol NMR       Date:  2011-09-16       Impact factor: 2.835

5.  Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F.

Authors:  A H Lucas; D M Granoff; R E Mandrell; C C Connolly; A S Shan; D C Powers
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.

Authors:  E Alonso de Velasco; A F Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.

Authors:  A I Fattom; J Sarwar; L Basham; S Ennifar; R Naso
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

8.  Structural, Biosynthetic, and Serological Cross-Reactive Elucidation of Capsular Polysaccharides from Streptococcus pneumoniae Serogroup 16.

Authors:  Chengxin Li; Katarzyna A Duda; Pernille L Elverdal; Ian C Skovsted; Christian Kjeldsen; Jens Ø Duus
Journal:  J Bacteriol       Date:  2019-09-20       Impact factor: 3.490

9.  A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.

Authors:  Fang Gao; Kay Lockyer; Karena Burkin; Dennis T Crane; Barbara Bolgiano
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

10.  Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Authors:  Allison E B Turner; Jonas E Gerson; Helen Y So; Daniel J Krasznai; Adrienne J St Hilaire; Donald F Gerson
Journal:  Synth Syst Biotechnol       Date:  2017-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.